Fleury S.A. (FLRY3.SA)
BRL 12.14
(-4.11%)
BRL 12.14
(-4.11%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.7 Billion BRL | 23.91% |
| 2022 | 1.27 Billion BRL | 19.57% |
| 2021 | 1.08 Billion BRL | 28.77% |
| 2020 | 853.24 Million BRL | -4.78% |
| 2019 | 880.63 Million BRL | 28.29% |
| 2018 | 697.59 Million BRL | 10.36% |
| 2017 | 620.24 Million BRL | 29.84% |
| 2016 | 574.78 Million BRL | 28.77% |
| 2015 | 376.05 Million BRL | 16.59% |
| 2014 | 303.32 Million BRL | 16.69% |
| 2013 | 268.77 Million BRL | -7.45% |
| 2012 | 309.92 Million BRL | 45.32% |
| 2011 | 222.81 Million BRL | -0.99% |
| 2010 | 201.57 Million BRL | 12.41% |
| 2009 | 173.78 Million BRL | 16.76% |
| 2008 | 141.86 Million BRL | 66.41% |
| 2007 | 91.66 Million BRL | 8.24% |
| 2006 | 62.32 Million BRL | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 523.31 Million BRL | 29.07% |
| 2024 Q2 | 520.99 Million BRL | 3.83% |
| 2023 Q1 | 373.08 Million BRL | 39.18% |
| 2023 Q4 | 366.01 Million BRL | -29.08% |
| 2023 FY | - BRL | 23.91% |
| 2023 Q2 | 459.92 Million BRL | 23.27% |
| 2023 Q3 | 516.08 Million BRL | 12.21% |
| 2022 Q4 | 268.06 Million BRL | -23.42% |
| 2022 FY | - BRL | 19.57% |
| 2022 Q1 | 333.88 Million BRL | 30.66% |
| 2022 Q2 | 290.63 Million BRL | -12.95% |
| 2022 Q3 | 350.05 Million BRL | 20.45% |
| 2021 Q2 | 222.14 Million BRL | -21.41% |
| 2021 FY | - BRL | 28.77% |
| 2021 Q1 | 282.67 Million BRL | -3.11% |
| 2021 Q4 | 255.53 Million BRL | -12.96% |
| 2021 Q3 | 293.58 Million BRL | 32.16% |
| 2020 Q4 | 291.75 Million BRL | -9.39% |
| 2020 FY | - BRL | -4.78% |
| 2020 Q2 | 15.2 Million BRL | -92.17% |
| 2020 Q1 | 194.15 Million BRL | 2.65% |
| 2020 Q3 | 322 Million BRL | 2018.42% |
| 2019 FY | - BRL | 28.29% |
| 2019 Q1 | 231.93 Million BRL | 69.76% |
| 2019 Q2 | 206.37 Million BRL | -11.02% |
| 2019 Q3 | 236.65 Million BRL | 14.67% |
| 2019 Q4 | 189.14 Million BRL | -20.08% |
| 2018 Q2 | 173.75 Million BRL | -4.74% |
| 2018 FY | - BRL | 10.36% |
| 2018 Q1 | 182.4 Million BRL | 42.1% |
| 2018 Q4 | 136.62 Million BRL | -23.94% |
| 2018 Q3 | 179.63 Million BRL | 3.38% |
| 2017 Q4 | 128.36 Million BRL | -20.44% |
| 2017 FY | - BRL | 29.84% |
| 2017 Q3 | 161.34 Million BRL | 7.97% |
| 2017 Q2 | 149.44 Million BRL | -12.83% |
| 2017 Q1 | 171.43 Million BRL | 77.8% |
| 2016 Q2 | 147.71 Million BRL | 20.54% |
| 2016 FY | - BRL | 28.77% |
| 2016 Q3 | 134.99 Million BRL | -8.61% |
| 2016 Q4 | 96.41 Million BRL | -28.58% |
| 2016 Q1 | 122.55 Million BRL | 46.94% |
| 2015 Q1 | 76.07 Million BRL | 11.68% |
| 2015 FY | - BRL | 16.59% |
| 2015 Q3 | 125.38 Million BRL | 6.08% |
| 2015 Q4 | 83.4 Million BRL | -33.48% |
| 2015 Q2 | 118.2 Million BRL | 55.38% |
| 2014 Q4 | 68.11 Million BRL | -40.33% |
| 2014 Q1 | 81.3 Million BRL | 83.88% |
| 2014 FY | - BRL | 16.69% |
| 2014 Q2 | 84.81 Million BRL | 4.32% |
| 2014 Q3 | 114.15 Million BRL | 34.59% |
| 2013 Q1 | 69.07 Million BRL | 90.64% |
| 2013 FY | - BRL | -7.45% |
| 2013 Q4 | 44.21 Million BRL | -51.59% |
| 2013 Q3 | 91.33 Million BRL | -8.12% |
| 2013 Q2 | 99.39 Million BRL | 43.91% |
| 2012 Q4 | 36.23 Million BRL | -59.24% |
| 2012 Q2 | 110.81 Million BRL | 43.25% |
| 2012 Q1 | 77.35 Million BRL | 53.73% |
| 2012 Q3 | 88.89 Million BRL | -19.78% |
| 2012 FY | - BRL | 45.32% |
| 2011 Q3 | 47.12 Million BRL | -13.08% |
| 2011 Q2 | 54.21 Million BRL | 0.59% |
| 2011 Q1 | 53.89 Million BRL | 24.5% |
| 2011 Q4 | 50.31 Million BRL | 6.78% |
| 2011 FY | - BRL | -0.99% |
| 2010 Q1 | 44.3 Million BRL | 0.0% |
| 2010 FY | - BRL | 12.41% |
| 2010 Q3 | 60.03 Million BRL | 7.6% |
| 2010 Q2 | 55.79 Million BRL | 25.92% |
| 2010 Q4 | 43.28 Million BRL | -27.9% |
| 2009 FY | - BRL | 16.76% |
| 2008 FY | - BRL | 66.41% |
| 2007 FY | - BRL | 8.24% |
| 2006 FY | - BRL | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Centro de Imagem Diagnósticos S.A. | 154.72 Million BRL | -999.431% |
| Diagnósticos da América S.A. | 2.2 Billion BRL | 22.96% |